Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Indalo Therapeutics

Request full access

A preclinical-stage biotechnology company

St. Louis, United StatesFounded 2014Biotech & Life Sciences

About Indalo Therapeutics

Indalo Therapeutics is a biopharmaceutical company focused on developing innovative treatments for serious fibrotic diseases. The company operates in the healthcare and pharmaceutical market, primarily targeting conditions where fibrosis, or the thickening and scarring of connective tissue, is a significant concern. Indalo's lead product, IDL 2965, is an oral drug candidate that uniquely inhibits multiple processes of pathological fibrosis. This includes the local activation of TGF-beta by both epithelial cells and fibroblasts, as well as the ability of a stiff extracellular matrix to promote fibroblast migration and survival. IDL 2965 began human clinical trials in 2019, marking a significant milestone in the company's development pipeline.

Indalo Therapeutics serves patients suffering from chronic fibrotic diseases, with a particular focus on liver fibrosis. The company's business model revolves around the discovery and development of novel integrin antagonists, which are compounds that inhibit integrins, proteins that play a key role in cell signaling and the progression of fibrosis. Revenue is generated through the development and potential commercialization of these therapeutic candidates, as well as through partnerships and collaborations with other pharmaceutical companies.

Source: Dealroom company data

Indalo Therapeutics in the St. Louis ecosystem

Live from Dealroom

The Indalo Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · St. Louis HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Indalo Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Indalo Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.